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VIM-2 carbapenemase-producing 
Pseudomonas aeruginosa in a patient 
from Port Elizabeth, South Africa 
To the Editor: We report on the emergence of a multidrug-resistant 
Pseudomonas aeruginosa isolate in a public hospital in Port Elizabeth, 
Eastern Cape Province, South Africa (SA), where the lack of anti-
biotic stewardship may have been a contributing factor. A 76-year-old 
woman was admitted in February 2014 following a non-pathological 
hip fracture. She received no perioperative antibiotic prophylaxis and 
4 days after hip replacement surgery she was started on cloxacillin 
(500 mg intravenous infusion 8-hourly) with suspected wound sepsis. 
Dislocation of the prosthetic joint necessitated a joint revision, after which 
she was discharged despite suffering from postoperative hip pain and 
bleeding from the surgical site. The antibiotic susceptibility profiles of P. 
aeruginosa isolated from superficial swab specimens prior to discharge 
revealed susceptibility to colistin only and resistance to ampicillin, 
amoxicillin-clavulanic acid, piperacillin-tazobactam, cefixime, cefuroxime, 
cefoxitin, cefotaxime, ceftazidime, cefepime, ertapenem, nitrofurantoin, 
trimethoprim-sulfamethoxazole, imipinem, meropenem, tigecycline, 
amikacin, gentamycin and ciprofloxacin. The Verona integron-mediated 
(VIM-2) carbapenemase encoding blaVIM-2 gene was also detected in the 
P.  aeruginosa isolate by polymerase chain reaction and gene sequencing. 
Following a deterioration of the surgical wounds, the patient 
was readmitted and started on cloxacillin (1 g intravenous infusion 
6-hourly). Deep tissue specimens confirmed the P. aeruginosa 
prosthetic joint infection, and 3 months after the initial admission 
her prosthesis was removed and colistin (9 mU loading dose followed 
by 4.5 mU 12-hourly) and rifampicin were started. The colistin was 
stopped after 10 days because of nephrotoxicity. During the period of 
colistin administration, 7/17 doses were missed which contributed to 
the selection of colistin-resistant P. aeruginosa isolates. The patient’s 
condition deteriorated with other complications such as gas gangrene 
on the right foot, pulmonary oedema, renal dysfunction and cellulits of 
the left shin and she died after 19 weeks in hospital. 
The blaVIM-2 gene is located within the class 1 integron (In 56), which is 
also known to carry other genes that encode aminoglycoside-modifying 
enzymes.[1] P. aeruginosa VIM-2-producing isolates have caused nosocomial 
infections worldwide.[2] In SA, VIM has been found in Klebsiella spp. and 
Providencia spp. in the Gauteng region and P. aeruginosa in a Cape Town 
hospital, and Acinetobacter baumannii was reported in Pretoria.[3-5] To our 
knowledge this was the first report of the detection of a VIM-2-producing 
P. aeruginosa isolate in a patient from a Port Elizabeth public hospital. 
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